Literature DB >> 3783461

Simultaneous first- and zero-order absorption of carbamazepine tablets in humans.

L E Riad, K K Chan, W E Wagner, R J Sawchuk.   

Abstract

The absorption kinetics of carbamazepine (5H-dibenz[b,f]azepine-5-carboxamide) in healthy adult volunteers was investigated following a single 400-mg (2 X 200-mg) oral dose of commercially available conventional tablets (Tegretol). Wagner-Nelson plots of the data from all subjects (n = 10) showed that the fraction remaining to be absorbed declined in a biphasic manner, suggesting a mixed order of absorption. A model assuming the absorption of carbamazepine by simultaneous first-order and zero-order rates was used to describe the overall absorption process. Model parameters (and their mean +/- SD values) were: alpha, the fraction of the dose absorbed at a first-order rate (0.646 +/- 0.070); Ka, the first-order absorption rate constant (0.45 +/- 0.13 h-1); and tdur, the duration of the zero-order absorption component (36.0 +/- 4.4 h). If complete absorption can be assumed, then the corresponding average zero-order rate was 4.0 mg X h-1. The results indicate that 35% of the available dose is absorbed at a zero-order rate. These data suggest a prolonged constant rate of absorption due to continued delivery during its transit in the intestine. In addition, an assessment of the mean absorption time, based on the parameters from the model described above, compared closely (7.95 versus 8.44 h) with the mean absorption time estimated from an analysis of the fraction remaining to be absorbed versus time plot using a noncompartmental approach.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783461     DOI: 10.1002/jps.2600750916

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Comparative in vitro study of six carbamazepine products.

Authors:  Pavan Kumar Mittapalli; Bandari Suresh; S S Q Hussaini; Yamasani Madhusudan Rao; Shashank Apte
Journal:  AAPS PharmSciTech       Date:  2008-02-16       Impact factor: 3.246

Review 2.  Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications.

Authors:  M Bialer
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

3.  Comparative bioavailability study of three sustained release quinidine formulations.

Authors:  W A Mahon; J S Leeder; M M Brill-Edwards; J Correia; S M MacLeod
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

4.  Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine.

Authors:  L E Riad; R J Sawchuk
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

Review 5.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

6.  Investigating Oral Absorption of Carbamazepine in Pediatric Populations.

Authors:  Philip Kohlmann; Cordula Stillhart; Martin Kuentz; Neil Parrott
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

7.  Individual and population pharmacokinetic compartment analysis: a graphic procedure for quantification of predictive performance.

Authors:  Staffan Eksborg
Journal:  J Drug Assess       Date:  2013-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.